This inventor holds 1 USPTO granted patent. Top assignee: The University of Manchester. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Alex George Baldwin: Inventor in Biomedical Research
Introduction
Alex George Baldwin is an inventor based in Manchester, Great Britain. His patent work is associated with The University of Manchester and focuses on compounds designed to inhibit the NLRP3 inflammasome.
Latest Patents
Baldwin is named on one patent, 1 patent: “Cyclic diarylboron derivatives as NLRP3 inflammasome inhibitors.” The patent discloses inhibitor compounds intended for treating diseases or conditions in which interleukin 1 beta activity is implicated. It also describes methods for synthesizing the compounds and pharmaceutical compositions containing them.
Career Highlights
The disclosed invention connects chemical compound development with potential therapeutic applications. Its focus on NLRP3 inflammasome inhibition reflects research into approaches for addressing conditions involving interleukin 1 beta activity.
Collaborations
Baldwin’s listed coworkers include Sally Freeman and David Brough. His patent is associated with The University of Manchester.
Conclusion
Alex George Baldwin’s patent contribution centers on cyclic diarylboron derivatives and their potential use in treatments targeting NLRP3 inflammasome activity.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile